BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 7, 2014
View Archived Issues
Takeda Pharmaceuticals charts milestones of second quarter of fiscal 2014
Read More
Daiichi Sankyo presents highlights of second quarter of fiscal 2014
Read More
Fujifilm to invest in PET radiopharmaceuticals
Read More
Xoma opens enrollment in phase III study of gevokizumab for pyoderma gangrenosum
Read More
AstraZeneca and Pharmacyclics collaborate on combination trials of ibrutinib in oncology
Read More
Cabozantinib extends progression-free survival in phase II trial in NSCLC
Read More
Astellas and Proteostasis Therapeutics form collaboration targeting the unfolded protein response
Read More
LEO Pharma licenses Japan Tobacco's JTE-052 for dermatology applications
Read More
Research uncovers novel gene mutations underlying familial hypertrophic cardiomyopathy
Read More
BioLineRx reports final results of phase I/II study for BL-7010
Read More
Alion and Medical Prognosis Institute to identify response biomarkers for ion channel inhibitor
Read More
Novel cystine derivatives inhibit stone formation in vivo
Read More
Aegerion Pharmaceuticals to acquire Myalept from AstraZeneca
Read More
New pan-RAF inhibitors effective in melanomas resistant to BRAF or BRAF/MEK inhibitors
Read More
Effectiveness of a bumped kinase inhibitor against toxoplasmosis
Read More
Novel ACC2 inhibitors disclosed by Boehringer Ingelheim
Read More
Incyte divulges novel FGFR-1, -2 and -3 inhibitors
Read More
Sage Therapeutics synthesizes novel GABA(A) receptor modulators
Read More
Astellas Pharma discloses new D1 receptor PAMs
Read More
Actelion researchers present novel antibacterial compounds
Read More
Investigators at CSIR report new anticancer rohitukine analogues
Read More
Beloranib as promising treatment of obesity and food-related behavior in Prader-Willi Syndrome
Read More
Spark Therapeutics' SPK-RPE65 receives FDA breakthrough therapy designation
Read More
Gilead files NDA for elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide for HIV
Read More
FDA advisory committee recommends approval of Triferic
Read More
FDA issues complete response letter to AEterna Zentaris for Macrilen NDA
Read More
F-star spins off assets into F-star Beta
Read More